Caffeine Infographic – references

1. Illy A. et al. (1995) Espresso Coffee. The chemistry of quality. Academic Press, London.
2. Harland B.F. (2000) Caffeine and nutrition. Nutrition, 7/8: 522-526.
3. Heckman M.A. et al. (2010) Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci, 75: R77-87.
4. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011). Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA Journal; 9(4): 2054.
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2011). Scientific Opinion on the substantiation of health claims related to caffeine and increase in physical performance during short-term high-intensity exercise (ID 737, 1486, 1489), increase in endurance performance (ID 737, 1486), increase in endurance capacity (ID 1488) and reduction in the rated perceived exertion/effort during exercise (ID 1488, 1490) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal; 9(4): 2053 [24 pp.]. doi:10.2903/j.efsa.2011.2053.
6. Arendash G.W. et al. (2006). Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience, 142(4): 941-52.
7. Cao C. et al. (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer’s disease transgenic mice. J Alzheimers Dis, 17(3): 681-97.
8. Costa J. et al. (2010) Caffeine exposure and the risk of Parkinson’s disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis, 20 Suppl 1: S221-38.
9. Wu J.N. et al. (2009) Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies.Int J Cardiol, 137(3): 216-25.
10. Ruxton C.H.S. (2008) The impact of caffeine on mood, cognitive function, performance and hydration: a review of benefits and risks. Nutr Bull, 33: 15–25.
11. Heaney R.P. (2002) Effects of caffeine on bone and the calcium economy. Food Chem Toxicol, 40: 1263-70.
12. Boekema P.J. et al. (2001) Functional bowel symptoms in a general Dutch population and associations with common stimulants. Netherlands J Med, 59(1): 23-30.
13. Committee on Obstetric Practice. (2010) Moderate caffeine consumption during pregnancy. Obstetrics & Gynecology. 116: 467-8.
14. Nehlig A. (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev, 23(4): 563-76.
15. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM V) ISBN 978-0-89042-554-1DSMV.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.